LUGHEZZANI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 10.517
AS - Asia 5.004
EU - Europa 2.294
SA - Sud America 1.842
AF - Africa 446
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 13
Totale 20.135
Nazione #
US - Stati Uniti d'America 10.325
SG - Singapore 2.988
BR - Brasile 1.568
CN - Cina 943
FI - Finlandia 487
VN - Vietnam 396
IE - Irlanda 381
NG - Nigeria 326
IT - Italia 322
DE - Germania 275
FR - Francia 195
GB - Regno Unito 154
HK - Hong Kong 149
AR - Argentina 112
NL - Olanda 112
CA - Canada 111
TR - Turchia 100
SE - Svezia 85
IN - India 80
RU - Federazione Russa 71
ID - Indonesia 56
BD - Bangladesh 53
EC - Ecuador 50
JP - Giappone 46
MX - Messico 46
ZA - Sudafrica 41
IQ - Iraq 36
UA - Ucraina 32
IL - Israele 31
CL - Cile 29
ES - Italia 26
PY - Paraguay 23
EG - Egitto 21
UZ - Uzbekistan 21
VE - Venezuela 21
MK - Macedonia 20
PL - Polonia 20
AU - Australia 19
BE - Belgio 18
CO - Colombia 18
CZ - Repubblica Ceca 17
DZ - Algeria 16
SA - Arabia Saudita 15
RO - Romania 14
MA - Marocco 12
PK - Pakistan 12
KE - Kenya 11
AT - Austria 10
A2 - ???statistics.table.value.countryCode.A2??? 9
LT - Lituania 9
UY - Uruguay 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
IR - Iran 8
KZ - Kazakistan 8
PH - Filippine 8
TT - Trinidad e Tobago 8
PE - Perù 7
TN - Tunisia 7
TW - Taiwan 7
JO - Giordania 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PT - Portogallo 5
DK - Danimarca 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
AZ - Azerbaigian 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
MD - Moldavia 3
NO - Norvegia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
OM - Oman 2
SN - Senegal 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
Totale 20.124
Città #
Wilmington 1.824
Chandler 1.314
Singapore 875
The Dalles 776
San Mateo 717
Shanghai 591
Ann Arbor 512
Dallas 499
Helsinki 485
Dublin 380
Ashburn 359
Leawood 330
Lawrence 327
Princeton 327
Benin City 325
Boardman 222
Fairfield 186
Woodbridge 186
Paris 184
Beijing 182
New York 179
Milan 162
Ho Chi Minh City 146
Hong Kong 138
São Paulo 95
Amsterdam 91
Los Angeles 85
London 84
Hanoi 79
Kocaeli 66
Toronto 65
Rio de Janeiro 58
Santa Clara 54
Seattle 48
Council Bluffs 46
San Diego 41
Norwalk 35
Belo Horizonte 33
Brasília 33
Columbus 33
Phoenix 29
Campinas 27
Munich 27
Orem 27
Pune 25
Curitiba 24
Haiphong 22
Tashkent 21
Salvador 20
Brooklyn 19
Guayaquil 19
Porto Alegre 19
San Jose 19
Falls Church 18
Johannesburg 18
Moscow 17
Naples 17
Thái Bình 17
Tokyo 17
Brussels 16
Da Nang 16
Guarulhos 16
Montreal 16
Ribeirão Preto 16
Des Moines 15
Falkenstein 14
Quito 14
Redmond 14
Takamatsu 14
Warsaw 14
Atlanta 13
Dhaka 13
Fortaleza 13
Frankfurt am Main 13
Monmouth Junction 13
Biên Hòa 12
Boston 12
Manaus 12
Manchester 12
Mexico City 12
New Delhi 12
Praia Grande 12
Recife 12
Nairobi 11
Olomouc 11
Andover 10
Asunción 10
Buenos Aires 10
Buffalo 10
Chennai 10
Contagem 10
Jakarta 10
Santiago 10
Cairo 9
Goiânia 9
Itaquaquecetuba 9
San Francisco 9
Skopje 9
Sorocaba 9
Stockholm 9
Totale 13.065
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 184
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 160
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 143
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 139
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 118
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 109
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 106
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 106
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 105
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 104
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 104
[Focal therapy and prostate cancer]. 103
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 103
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 103
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 98
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 97
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 95
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 94
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 90
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 90
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 89
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 86
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 86
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 86
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 85
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 84
The Management of Small Renal Masses: Renal Anatomy and Physiology 84
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 83
Clinical and pathological predictors of persistent T1 HG at second resection 82
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 80
[The added value of robotic surgery]. 79
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 78
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 78
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 78
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 77
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 77
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 77
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 76
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 75
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 74
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 73
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 72
Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies 72
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 72
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 72
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma 72
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 72
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 71
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 71
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 71
MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE 70
How Should We Report Incontinence After Radical Prostatectomy? 69
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 69
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 69
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 69
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 68
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 68
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 68
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 67
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 67
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 67
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 67
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. 66
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 66
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 66
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 66
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 66
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 66
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 66
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 66
Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer 65
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms? 65
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 65
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 65
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 65
Robot-Assisted Pyeloplasty 65
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 65
THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY. 64
Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction 64
Pyeloplasty using the novel da Vinci single site robotic platform for the surgical treatment of uretero-pelvic junction obstruction: The technique 64
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 64
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 63
The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study 63
Complications and Quality of Life After Template-assisted Transperineal Prostate Biopsy in Patients Eligible for Focal Therapy 63
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 63
Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study) 63
Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy 62
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 62
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 62
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma 62
The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study 61
SENSITIVITY OF [-2]PROPSA AS AN ULTRASENSITIVE PSA SURROGATE FOR THE PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: AN OBSERVATIONAL COHORT STUDY 61
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 61
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 61
LIQUID BIOPSY BY PROSTATE-DERIVED TUMOR CELLS ENRICHED FROM SEMINAL FLUID (SF): THE SEMEN PROSTATE CANCER TUMOR ELEMENTS (SPECTRE) PROJECT. 61
ASSESSING THE DIAGNOSTIC ACCURACY OF MICRO-ULTRASOUND FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: RESULTS FROM A SINGLE-INSTITUTIONAL PRELIMINARY EXPERIENCE 61
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project 60
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 60
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 60
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 60
Totale 7.809
Categoria #
all - tutte 165.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.262 0 0 0 0 0 1.076 442 210 775 369 2 388
2021/20221.687 65 39 32 367 17 21 48 254 151 210 426 57
2022/20234.002 723 118 403 404 381 311 16 292 671 381 259 43
2023/20242.286 184 266 446 117 63 204 141 174 39 42 232 378
2024/20254.174 90 79 48 71 118 422 192 456 599 1.012 473 614
2025/20264.828 1.431 609 833 1.388 354 213 0 0 0 0 0 0
Totale 20.495